Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member
 Nominating and Corporate Governance Committee CharterCompensation Committee CharterAudit Committee Charter
John  Schmid  
John  Schmid

John Schmid has served on our Board of Directors since June 2015. Mr. Schmid served as Chief Financial Officer of Auspex Pharmaceuticals, Inc., a publicly traded biotechnology company, from September 2013 until its sale to Teva Pharmaceuticals, Inc. (NYSE: TEVA) in June 2015. Prior to that, he co-founded Trius Therapeutics, Inc., where he served as Chief Financial Officer from June 2004 until its merger with Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) in September 2013. Mr. Schmid also served as... 
Committee Member   Chairperson
Bryant Fong  
Bryant Fong

Bryant Fong is a founding General Partner at Biomark Capital, a life sciences private equity fund formed in 2013. Prior to Biomark Capital, Mr. Fong was a Managing Director at Burrill & Company, where he spent almost 16 years investing in and managing investments in private and public companies in the biotechnology industry. Some of Mr. Fong’s notable investments include Pharmasset, Galapagos, Ferrokin Biosciences, Ceptaris Therapeutics, and Novadaq Technologies. Mr. Fong currently serves on the... 
  Committee Member Committee Member
Greg  Robitaille  
Greg  Robitaille

Greg Robitaille is responsible for corporate development at Water Street, where he manages the strategic development and acquisition activities of the firm’s specialty health care distribution companies. Mr. Robitaille also spent 10 years with Equity Group Investments, the primary investment company of Sam Zell. He holds a Bachelor’s degree from Hamilton College and an MBA from Columbia University. ... 
  Chairperson Committee Member
Linda M. Szyper 
Linda M. Szyper

Linda M. Szyper has served on our board of directors since April 2018 and has been the Chief Operating Officer at McCann Health since January 2018. From September 2014 to March 2017, Ms. Szyper was the Chief Commercial Officer and President, US Operations at Circassa Pharmaceuticals plc, or Circassa. Prior to joining Circassa, Ms. Szyper was the Chief Development Officer, PHCG Global Development of Publicis Healthcare Group from January 2008 to September 2014. Ms. Szyper holds a MBA from DePaul ... 
Committee Member Committee Member  
Beth Hecht 
Beth Hecht

Beth Hecht joined Neos Therapeutics Board of Directors in September 2015. Beth serves as Managing Director and Chief Legal and Administrative Officer of Auven Therapeutics, a global private equity firm with offices in the U.S., Bermuda, St. Thomas USVI and Switzerland that acquires and develops pharmaceutical products that address unmet medical needs. She has over twenty years of senior management experience in the pharmaceutical and biotechnology industries, building and leading legal, complian... 
Chairperson   
Jim Robinson 
Jim Robinson

Jim Robinson has served on our Board of Directors since January 2019 and is currently the President and Chief Operating Officer of Alkermes, where he leads the commercial, operations, business development, and human resources functions. Prior to joining Alkermes, he joined Astellas in 2005 as vice president of health systems, rising to President of Astellas Americas Operations in 2016. Prior to joining Astellas, he served as an executive at the former Schering-Plough Corporation, which was acqui... 
Committee Member Committee Member